Posted by on Feb 26, 2019 in Breast cancer | 0 comments

In a nutshell This trial aims to investigate a new cancer medicine called xentuzumab together with exemestane (Aromasin) and everolimus (Afinitor) in women who have breast cancer that has spread. The main outcome that will be measured is how long the patients go without cancer growing.  The details Xentuzumab is a new medication that works...

Read More